My Member
Message Center
trending topics
market reports
-
MEDICAL JAPAN 2025 OSAKA Returns to Showcase Global Innovations
2025-02-17
-
Visit MEDICAL JAPAN 2023 TOKYO and take full advantage of the business opportunities!
2023-09-01
-
US to distribute 400 million free N95 masks at CVS, Walgreens in COVID fight
2022-01-21
-
Ethiopia receives additional 2.2 mln doses of Chinese-donated COVID-19 vaccines
2022-01-21
-
Hong Kong researchers say they develop novel material able to kill COVID-19 virus
2022-01-14
-
10 million more Chinese doses on way for Kenya
2022-01-14
-
Sino-African ties on track for a brighter future
2022-01-07
-
Efforts urged to boost COVID-19 vaccine production capacity in poor countries
2022-01-07
-
UAE approves Sinopharm's new protein-based COVID-19 vaccine
2022-01-07
-
UAE approves Sinopharm's new protein-based COVID-19 vaccine
2022-01-07
-
Study: Effective vaccine response among young
The domestic COVID-19 vaccine developed by Sinovac Biotech is safe and can elicit a strong antibody response in people aged 3 to 17 in early and mid-stage clinical trials
2021-07-05 -
China-made vaccines vital to pandemic effort
A year ago this month, tech billionaire and philanthropist Bill Gates told fellow donors at the Global Vaccine Summit that to beat the COVID-19 pandemic, the world would need a "breakthrough in generosity" as well as one in science.
2021-06-23 -
China to promote use of TCM in prevention, treatment of infectious disease outbreaks
BEIJING -- Chinese health authorities have issued a guideline to give full play to the role of traditional Chinese medicine (TCM) in the prevention and treatment of new outbreaks of infectious diseases.
2021-06-17 -
Study shows generic drugs match name-brand counterparts
A recent study led by the National Healthcare Security Administration shows 14 generic drugs included in the national drug bulk-buy program are as safe and effective as their name-brand counterparts, the administration said on Wednesday.
2021-06-11 -
Chinese inactivated vaccines effective against COVID-19 in phase-3 human trials: study
Two inactivated vaccines developed by Sinopharm have shown to be safe and effective against COVID-19 in phase-3 human trials, according to a study published this week in The Journal of the American Medical Association.
2021-05-28 -
Hong Kong-led study discovers simeprevir as potent treatment for COVID-19
A Hong Kong-led global study showed that a hepatitis C virus drug simeprevir can strongly suppress the replication of SARS-CoV-2, the virus that causes COVID-19.
2021-05-11 -
Chinese scientists discover gene associated with epilepsy
Chinese scientists have recently discovered a gene responsible for epilepsy, a neurological disorder of the brain.
2021-05-10 -
Chinese vaccines: A key weapon against COVID-19
China is at the forefront of developing,administering and distributing COVID-19 vaccines.
2021-03-10 -
Sinopharm chairman says vaccines can protect against COVID variants
Early research shows that the inactivated COVID-19 vaccines produced by Sinopharm can provide protection against 10 mutated variants of SARS-CoV-2,said Yu Qingming, Sinopharm's board chairman and a deputy to the National People's Congress.
2021-03-05 -
Medical industry experts discuss opportunities created by COVID-19
Despite the challenges created, the COVID-19 pandemic has presented many opportunities for the health sector as the public is now more concerned about their health than ever before.
2021-01-12